FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2557591569> ?p ?o ?g. }

• W2557591569 abstract "Abstract Abstract 2263 Introduction: Mechanical circulatory support systems are used for the treatment of end-stage heart failure. In children, extracorporeal membrane oxygenation systems and centrifugal pumps have been used widely in the past, but are only suitable for short term use and intensive care is obligatory. The Berlin Heart is a VAD which is an extracorporeal pulsatile pneumatic system which can be placed as a bridge to transplant or recovery and allows patients to be mobile and to lead an almost normal life. As with placement of any mechanical device, aggressive anticoagulant therapy is needed due to the increased risk of thrombosis and therefore an increased risk of bleeding associated with the treatment. Here we report the complications seen in 13 children on VAD's from a single institution. Methods: Patient medical records were reviewed to obtain the information on complications and associated coagulation test results. Tests of hemostasis and thrombosis were performed in the authors' CAP accredited Coagulation Laboratory at the Children's Hospital of Michigan. Results: Thirteen children with a mean age of 42 months (range 3 weeks to 13 years) received a VAD as a bridge to transplant between 2006 and 2011. There were 7 males and 6 females, 9 were African American and 5 Caucasian. 10/13 patients were on ECMO for a short duration (1–15days) prior to VAD implantation. The duration of VAD implantation varied from 8 days to 8 months. 9/13 eventually received a heart transplant. Anticoagulation was monitored according to the Berlin Heart protocol. There were 4 deaths, all in infants <7months of age. Complications included thrombosis in 7 patients and bleeding in 5, some of whom had both. Time to thrombotic complications varied from day of implant to 14 days post implantation. Thrombotic complications included fibrin deposits in the VAD to strokes. Assessment of risk factors for thrombosis and bleeding showed that 3/10 patients were heterozygous for the MTHFR gene mutation, 1/10 had a low protein S and 2/10 had a low protein C. 5/7 patients with thrombosis had concurrent systemic or respiratory infections. ATIII was monitored and replaced to keep over 70% per protocol recommendations. Reactive thrombocytosis seen in some patients with thrombosis was associated with an increase in MA on thromboelastography despite administration of antiplatelet drugs. Bleeding complications varied from hemopericardium and intracranial hemorrhage to GI bleeding. Anticoagulation was monitored using thromboelastography with platelet mapping (monitoring antiplatelet agents), PTT and unfractionated (UFH level) or low molecular weight heparin levels respectively; UFH levels were found to be more useful for monitoring heparin anticoagulation than PTT. PTT was found to be low secondary to elevated Factor VIII activity resulting in poor correlation to heparin levels. Thromboelastography Platelet mapping assays were used to monitor aspirin and platelet ADP receptor antagonists, but did not correlate with traditional whole blood platelet aggregation studies. Conclusions: While thrombosis and bleeding complications are commonly seen in adult patients on VAD's, pediatric data in this population are limited and monitoring for the complications is inadequate. At our institution, infants who received VAD's had a poor outcome, but larger studies are needed to evaluate if there are complications unique to this age group. Current monitoring strategies are not always successful in predicting the occurrence of complications. Defects in fibrinolysis and increased thrombin generation may predispose to thrombotic manifestations. Tests to detect elevated thrombin generation and evaluation of fibrinolysis using modified thromboelastography may be useful to predict an increase in thrombotic potential which may assist us in improving the outcome. Disclosures: No relevant conflicts of interest to declare." @default.
• W2557591569 created "2016-12-08" @default.
• W2557591569 creator A5015867468 @default.
• W2557591569 creator A5034959097 @default.
• W2557591569 creator A5047364086 @default.
• W2557591569 creator A5051042249 @default.
• W2557591569 creator A5056108298 @default.
• W2557591569 creator A5057874919 @default.
• W2557591569 date "2011-11-18" @default.
• W2557591569 modified "2023-09-30" @default.
• W2557591569 title "Hematologic Complications Associated with Ventricular Assist Devices (VAD's) in 13 Children From a Single Center" @default.
• W2557591569 doi "https://doi.org/10.1182/blood.v118.21.2263.2263" @default.
• W2557591569 hasPublicationYear "2011" @default.
• W2557591569 type Work @default.
• W2557591569 sameAs 2557591569 @default.
• W2557591569 citedByCount "0" @default.
• W2557591569 crossrefType "journal-article" @default.
• W2557591569 hasAuthorship W2557591569A5015867468 @default.
• W2557591569 hasAuthorship W2557591569A5034959097 @default.
• W2557591569 hasAuthorship W2557591569A5047364086 @default.
• W2557591569 hasAuthorship W2557591569A5051042249 @default.
• W2557591569 hasAuthorship W2557591569A5056108298 @default.
• W2557591569 hasAuthorship W2557591569A5057874919 @default.
• W2557591569 hasConcept C141071460 @default.
• W2557591569 hasConcept C164705383 @default.
• W2557591569 hasConcept C2776858399 @default.
• W2557591569 hasConcept C2778198053 @default.
• W2557591569 hasConcept C2778774980 @default.
• W2557591569 hasConcept C2778849806 @default.
• W2557591569 hasConcept C2779326848 @default.
• W2557591569 hasConcept C2780868729 @default.
• W2557591569 hasConcept C71924100 @default.
• W2557591569 hasConceptScore W2557591569C141071460 @default.
• W2557591569 hasConceptScore W2557591569C164705383 @default.
• W2557591569 hasConceptScore W2557591569C2776858399 @default.
• W2557591569 hasConceptScore W2557591569C2778198053 @default.
• W2557591569 hasConceptScore W2557591569C2778774980 @default.
• W2557591569 hasConceptScore W2557591569C2778849806 @default.
• W2557591569 hasConceptScore W2557591569C2779326848 @default.
• W2557591569 hasConceptScore W2557591569C2780868729 @default.
• W2557591569 hasConceptScore W2557591569C71924100 @default.
• W2557591569 hasLocation W25575915691 @default.
• W2557591569 hasOpenAccess W2557591569 @default.
• W2557591569 hasPrimaryLocation W25575915691 @default.
• W2557591569 hasRelatedWork W1948695832 @default.
• W2557591569 hasRelatedWork W1968095671 @default.
• W2557591569 hasRelatedWork W2033846330 @default.
• W2557591569 hasRelatedWork W2054278098 @default.
• W2557591569 hasRelatedWork W2062137387 @default.
• W2557591569 hasRelatedWork W2096402870 @default.
• W2557591569 hasRelatedWork W2150719457 @default.
• W2557591569 hasRelatedWork W2156117572 @default.
• W2557591569 hasRelatedWork W2333144042 @default.
• W2557591569 hasRelatedWork W2335481781 @default.
• W2557591569 hasRelatedWork W2413289868 @default.
• W2557591569 hasRelatedWork W2460572315 @default.
• W2557591569 hasRelatedWork W2547476983 @default.
• W2557591569 hasRelatedWork W2587335093 @default.
• W2557591569 hasRelatedWork W2734503003 @default.
• W2557591569 hasRelatedWork W2773353475 @default.
• W2557591569 hasRelatedWork W2901159123 @default.
• W2557591569 hasRelatedWork W2922135140 @default.
• W2557591569 hasRelatedWork W3114366470 @default.
• W2557591569 hasRelatedWork W4226284510 @default.
• W2557591569 isParatext "false" @default.
• W2557591569 isRetracted "false" @default.
• W2557591569 magId "2557591569" @default.
• W2557591569 workType "article" @default.